Throat swelling, trouble breathing, fainting or collapse during an allergic reaction is an emergency. Call 911.
It measures the amount of tryptase, an enzyme packed into the storage granules of mast cells, in a sample of serum. Mast cells sit in tissue rather than circulating in blood, concentrated in the skin, the lining of the airways and gut, and the tissue around blood vessels. Tryptase is the most abundant protein they store, which makes it a practical stand in for what those cells are doing.
Two different things reach the bloodstream. A small amount of immature protryptase leaks out continuously, whether or not anything is happening, so a resting sample mostly reflects how many mast cells a person carries and how their genes are set up. When mast cells are triggered and degranulate, they release mature tryptase in a burst, and that burst is what a sample drawn during or just after a reaction is looking for.
Research suggests that tryptase release is a core feature of type I hypersensitivity, the immediate reaction pattern behind many food, venom and medication allergies, which is why it is the main blood marker drawn after a suspected anaphylactic event 1.
Results are reported in ng/mL, which is numerically identical to µg/L, so 5 ng/mL and 5 µg/L describe the same concentration. The number alone is not a diagnosis. Its meaning comes from when the sample was taken and what the same person's resting level looks like.
It is ordered to answer two quite different questions, and the timing of the draw decides which one it answers. The first question is whether a frightening episode, such as sudden hives with wheeze and a drop in blood pressure, involved widespread mast cell activation. A sample taken close to the event can support that picture when the level climbs and then falls back.
The second question is whether a person's resting level is higher than expected when nothing is happening. That is a different investigation, and it points toward inherited and acquired causes rather than a single reaction. Research suggests that resting serum tryptase in the general population is shaped by both inherited factors and acquired ones, which is why a single raised reading is a starting point rather than a conclusion 2.
There is a third, quieter use. Someone who has had repeated unexplained episodes of flushing, faintness, abdominal cramping or near collapse may be investigated for a mast cell driven cause, and baseline tryptase is one of the first blood markers in that workup.
What the test cannot do is confirm which trigger was responsible. It reflects mast cell activity, not the food, sting or medication behind it. Identifying a trigger relies on the history of the episode and on allergy specific testing that a clinician selects.
As soon as the person is stable, because the window is short. Mature tryptase enters the circulation quickly after mast cells degranulate and then clears, so a sample taken hours later can look entirely ordinary even after a severe episode. Studies indicate that serum tryptase rises within roughly 15 to 30 minutes of symptom onset, peaks within the first one to two hours, and then declines, which is why emergency teams aim to draw it early and record the exact time 3.
In practice that means three pieces of information travel with the sample. The time symptoms began, the time the blood was taken, and what the symptoms actually were. Without those, the result is difficult to interpret later.
Some clinicians take more than one acute sample, for example one early and one a few hours later, to capture the rise and the fall rather than a single point. A repeat sample also helps separate a temporary spike from a level that was already high before anything happened.
If the draw was missed in the emergency department, the opportunity for an acute measurement has passed, but the investigation is not over. A baseline sample taken later still carries useful information. Never assume a missed draw means the reaction did not matter. It is worth telling the clinician reviewing the episode exactly what happened and when.
A baseline is the resting level measured when the person has fully recovered and no reaction is in progress, and it exists to give the acute number something to be compared against. Clinicians usually arrange it well after symptoms have settled, often at a follow up visit rather than on the same day, so that any spike has had time to clear.
That comparison is the heart of the test. A peak of 9 ng/mL means something very different in a person whose resting level is 3 ng/mL than in a person who always sits near 9 ng/mL. Studies indicate that comparing a peak value against the same person's own baseline, using a proportional rise plus a fixed increment rather than a single population cut-off, is the more informative way to read an acute sample 3. The commonly applied calculation looks for a peak that exceeds about 120 percent of baseline plus 2 ng/mL.
Baseline also stands on its own. A resting level that is consistently above the usual range raises a separate line of questions about inherited tryptase genetics, kidney function and bone marrow conditions, none of which can be settled by one blood draw.
One baseline is rarely the final word. Levels can drift, assays differ between laboratories, and a single value taken soon after an episode may still be settling. A clinician may repeat it before drawing any conclusion.
Most laboratories report an upper limit for resting serum tryptase near 11.4 ng/mL in adults, although the exact figure depends on the assay and the laboratory.
| Measurement | Typical lab reference range | How it is usually read |
|---|---|---|
| Resting (baseline) serum tryptase, adults | Upper limit commonly reported near 11.4 ng/mL | A single value above the limit is a prompt for repeat testing and a wider look, not a diagnosis |
| Acute (peak) serum tryptase | No fixed cut-off | Compared with the same person's own baseline, using a proportional rise plus a fixed increment |
| Persistently raised baseline | Outside the typical range | Baselines flagged around 20 ng/mL and above are commonly the point at which specialists broaden the assessment |
Reference ranges vary by laboratory, assay, age and sex, so a result should always be read against the range printed on the report that produced it. Results from two different laboratories are not always directly comparable, which is one reason clinicians prefer to track a person using the same laboratory where possible.
There is no FitScript optimal range published for tryptase, so the figures above are standard laboratory reference ranges only, stated as typical.
A raised result shows that more tryptase was circulating than the reference range expects, and the next step is working out whether that was a temporary spike or a steady state. A transient rise that falls back to a normal resting level afterwards fits the pattern of acute mast cell activation during a reaction. A level that stays high between episodes points somewhere else.
Several non-allergic situations sit behind a persistently raised resting level. Elevated serum tryptase is associated with conditions outside anaphylaxis, including reduced kidney function and certain blood and bone marrow disorders, which is why a high baseline usually triggers a broader assessment rather than an allergy focused one 4.
Inherited genetics account for a meaningful share of raised baselines. Elevated resting tryptase is associated with carrying extra copies of the alpha-tryptase gene, a trait that runs in families and is now recognised as a common reason for a high number in an otherwise well person 2.
Mast cell tryptase also appears in contexts well away from allergy. Research suggests that mast cell tryptase participates in cardiovascular disease processes, including atherosclerosis and aneurysm formation, which is one reason the enzyme attracts interest beyond the allergy clinic 5.
So the honest reading of a high value is this. The observation is a number above the range. What it may reflect spans inherited traits, kidney function, bone marrow conditions and recent mast cell activation. What to do about it is a conversation with a clinician, who decides whether repeat testing, genetic testing or specialist referral makes sense. A result outside the standard range is suboptimal, not a verdict, and it should never be ignored.
A normal result does not rule out anaphylaxis. This is the single most misunderstood part of the test, and it matters because people sometimes leave an emergency department reassured by a number that was never capable of reassuring them.
There are several reasons a sample can come back unremarkable after a genuine severe reaction. The blood may have been drawn outside the narrow window when the level is elevated. The reaction may have risen and fallen before anyone reached a vein. And the size of the rise differs by trigger and by the type of reaction, so a real event can produce a change too small to cross a population cut-off. Studies indicate that a peak value within the standard range does not exclude anaphylaxis, and that the clinical picture remains the basis for the diagnosis 3.
The practical consequence is that a person who had a severe reaction with a normal tryptase still needs the episode taken seriously. The description of what happened, how fast it came on, which body systems were involved and how it resolved carries more weight than the laboratory value.
A normal baseline measured weeks later is also useful information in its own right, because it makes an underlying raised resting level less likely. That narrows the investigation rather than ending it.
Hereditary alpha-tryptasemia is an inherited trait in which a person carries extra copies of the gene encoding alpha-tryptase, and it raises the resting tryptase level without any reaction taking place. It is passed down in families, so a high baseline in one person often means relatives share the trait.
Its practical importance is twofold. First, it explains a high resting number in people who are otherwise well, which prevents an unnecessary hunt for rarer causes. Research suggests that inherited alpha-tryptase gene copy number is one of the main determinants of where a person's resting serum tryptase sits 2.
Second, it appears to shape how reactions behave. Research suggests that increased alpha-tryptase copy number acts as a risk-modifying factor for the severity of mast cell mediated reactions, which is why it is of interest in people who have had unusually severe episodes 6.
Confirming the trait requires a specific genetic test that counts gene copies, not the standard serum measurement. That test is ordered by a clinician when the clinical picture warrants it, and the result is interpreted alongside the person's history rather than in isolation.
Carrying the trait is not the same as having a mast cell disease, and many people with it live without ever noticing. What it does is change the meaning of a high resting number, which is exactly the kind of context a single laboratory value cannot supply on its own.
Four things move it most. The first is timing relative to a reaction, which dominates everything else, because an acute sample and a resting sample measure different states of the same system.
The second is inherited genetics. Resting levels differ between people from birth, and much of the spread in the general population traces back to inherited determinants rather than anything a person does 2.
The third is kidney function. Clearance matters for a circulating protein, and reduced kidney function is associated with higher resting tryptase in the absence of any allergic process 4.
The fourth is the laboratory itself. Different assays and different reporting conventions produce results that are not perfectly interchangeable, so a change between two laboratories is not necessarily a change in the person.
What the number is generally insensitive to is short term lifestyle noise. There is no food, workout or sleep adjustment that meaningfully rewrites a resting tryptase level, and no reason to attempt one. Anyone tempted to chase this marker with self directed changes is chasing the wrong thing. The useful variables here are timing, repetition and context, all of which belong in a clinician's hands. This page is educational and not medical advice.
It is a standard venous blood draw into a serum tube, usually from the arm, taking a minute or two. No fasting is normally required, and nothing about the preparation differs from a routine blood test.
The detail that matters is documentation. For an acute sample, the time of symptom onset and the exact time of the draw should be recorded on the request, because the result cannot be interpreted without them. For a baseline sample, it helps to note that the person has been free of symptoms and how long it has been since the last episode.
In the laboratory, the sample is spun to separate serum, and tryptase is measured using an immunoassay that detects both the immature and mature forms together. That is why a resting sample mostly reports the continuous leak and an acute sample captures the leak plus the burst.
Turnaround depends on whether the assay runs in house or is sent to a reference laboratory, and it varies by provider, so check with the ordering clinic rather than assuming a date. Results arrive with the laboratory's own reference range printed alongside, and that printed range is the one to read against.
If a repeat is requested, using the same laboratory keeps the comparison clean.
Eosinophils are a type of white blood cell counted on a standard differential, and they surface in the same investigations as tryptase because both can be raised in allergic and mast cell related conditions. Typical lab reference ranges put them at 0 to 6 percent of white cells, while FitScript's optimal range is 1 to 4 percent, an optimization target rather than a diagnostic cut-off. Ranges vary by lab, age and sex. A raised eosinophil count sitting next to a raised resting tryptase is a pattern a clinician reads as a whole rather than marker by marker. For what the count measures, how it is run and how to interpret your own number, the full Eosinophils guide covers it in depth.
Tryptase is rarely ordered alone, because it answers only part of the question. The table below shows what commonly travels with it and what each one contributes.
| Marker | What it reflects | When it is typically used |
|---|---|---|
| Serum tryptase, acute | A burst of mast cell activation during an episode | Drawn close to a suspected anaphylactic reaction |
| Serum tryptase, baseline | Resting mast cell burden and inherited tryptase genetics | Drawn after full recovery, as the comparison point |
| Total and allergen specific IgE | Sensitisation to specific triggers in immediate type allergy | When a trigger needs identifying after a reaction |
| Complete blood count with differential | White cell populations, including eosinophils | Alongside a raised baseline, to see the wider blood picture |
| Kidney function markers | Clearance of circulating proteins | When a raised resting level needs a non-allergic explanation |
| Alpha-tryptase gene copy number | Inherited cause of a high resting level | When baseline is persistently raised in a well person |
Allergen specific testing deserves a note. Tryptase says mast cells were active, but it never names the trigger. Identifying the trigger relies on the history plus allergy specific testing, which a clinician selects based on what the person was exposed to.
Kidney markers often get added quietly, and for good reason, since elevated resting tryptase is associated with reduced kidney function independently of any allergic process 4. Reading the panel together is what turns a set of numbers into a usable picture.
Any result outside the standard range is worth discussing, and a few situations warrant doing it promptly rather than at the next routine visit.
A resting level that stays above the laboratory's upper limit on a repeat sample is one. A first raised value can reflect timing or assay variation, but a confirmed pattern deserves a plan, which may include genetic testing or referral to a specialist.
A history of severe reactions, especially to stings or medications, is another, whatever the number did. Research suggests that alpha-tryptase gene copy number modifies the severity of mast cell mediated reactions, which makes the combination of severe episodes and a raised baseline a reason for specialist input 6.
Recurrent unexplained episodes of flushing, faintness, abdominal cramping or near collapse also justify a prompt conversation, since those are the symptoms the resting measurement was designed to help investigate.
And the line that overrides all of the above. Throat swelling, difficulty breathing, severe light-headedness or collapse during a reaction is an emergency, and the response is to call 911, not to arrange a blood test.
Any next step, including whether a treatment is appropriate at all, is a clinical decision. Treatment decisions belong to a licensed provider, who evaluates the person rather than the number. Bring your results to a clinician or licensed provider and go through them together.
Tracking means repeating the resting measurement on a sensible schedule and reading it alongside the rest of the blood picture, not watching a single value for small movements. Because resting tryptase is largely set by inherited factors and by organ function, it tends to be stable in a well person, and stability is itself useful information.
The value of a series shows up in two ways. A level that was raised once and normal twice afterwards usually reflects timing or assay variation. A level that climbs steadily over repeated samples is a different signal, and it is the kind of trend a clinician wants to see rather than hear about after the fact.
Context comes from the markers around it. Eosinophils, kidney function and the white cell differential move the interpretation of the same tryptase number in different directions, which is why panel style testing beats one off measurements for anyone with an unexplained result.
Memberships built around repeat testing work this way by design. FitScript covers 150+ biomarkers tested per year, with interpretation by Atlas, its AI health advisor, and any treatment decision made by a licensed provider after reviewing the member. The point of a series is context, not reassurance, and an abnormal result in a series still goes to a clinician.
For related reading, the ige blood test guide explains how immunoglobulin E testing works and where it fits alongside mast cell markers in an allergy workup.
It measures an enzyme stored in mast cells, using a standard blood draw. Clinicians use it in two ways, as a sample taken soon after a severe allergic reaction to help confirm widespread mast cell activation, and as a resting baseline to see whether a person's usual level sits above the laboratory's range. The result is interpreted alongside the history of what happened, never on its own.
No fasting is normally required, and the draw itself is the same as any routine blood test from the arm. What matters more than preparation is timing. For a resting baseline, the sample should be taken once symptoms have fully settled, and the ordering clinic will tell you when that is.
As soon as the person is stable, because the level rises quickly and then falls back within hours. Emergency teams aim to draw it early and record both the time symptoms started and the time of the draw. If the window is missed, a later baseline sample still adds useful information to the picture.
No. A level inside the standard range after a severe reaction is common, and it does not exclude anaphylaxis. The description of the episode, how fast it came on and which body systems were involved, carries more weight than the laboratory value. A severe reaction with a normal result still needs a clinician's review.
It means more of the enzyme was circulating than the laboratory's range expects, which has several possible explanations rather than one. Inherited extra copies of the alpha-tryptase gene, reduced kidney function, and certain blood and bone marrow conditions all sit on that list. A single high value is a reason to repeat the test and widen the assessment, not a diagnosis.
Yes, it is an inherited trait involving extra copies of the alpha-tryptase gene, so it often runs in families. It raises the resting level without any reaction taking place, which is why it explains a number of otherwise puzzling high baselines. Confirming it requires a specific genetic test that counts gene copies, ordered by a clinician.
There is no single schedule, and the interval depends on why it was measured in the first place. A raised value is usually repeated to confirm it before anything is concluded, and a confirmed raised baseline may be followed over time alongside other blood markers. The clinician who ordered the test sets the timing.
A clinician does, after reviewing the result alongside your history, your symptoms and the rest of your blood work. That may mean a repeat sample, additional markers, genetic testing or a referral to a specialist. Treatment decisions belong to a licensed provider, and no abnormal result should be ignored or self managed.